跳至主要内容
临床试验/NCT01122797
NCT01122797已完成不适用

Study of Metabolism Influence in Human Alcoholic Liver Disease

Erasme University Hospital1 个研究点 分布在 1 个国家目标入组 658 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
658
试验地点
1
主要终点
Assessment of fibrosis and steatosis by liver biopsy in alcoholic liver disease patients.

研究概览

简要总结

Increasing evidence attests the influence of multiple metabolic genetic risk factors in the progression of alcoholic liver disease. Deleterious pathways involved in metabolism such as lipid peroxidation and cytokines have been implicated in promoting inflammation leading to fibrosis increase and liver injury progression. The aim of this study was to assess the role of rs738409 single nucleotide polymorphism in the PNPLA3 gene in alcoholic liver disease patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Excess alcohol intake
  • Abnormal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) or a suspicion of cirrhosis related to ALD
  • Caucasian ethnicity

排除标准

  • Presence of any other chronic liver disease
  • Co-infection with human immunodeficiency virus
  • Inclusion Criteria:
  • Caucasian ethnicity
  • Exclusion Criteria:
  • Presence of a disease

结局指标

主要结局

Assessment of fibrosis and steatosis by liver biopsy in alcoholic liver disease patients.

After liver histology assessment for liver liver dammage a potential correlation of fibrosis and steatosis was studied with rs738409 PNPLA3 polymorphism

次要结局

未报告次要终点

研究者

发起方
Erasme University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验